Today: 27 April 2026
Why Super Micro Computer stock is sliding: Goldman starts SMCI at Sell with $26 target
13 January 2026
2 mins read

Why Super Micro Computer stock is sliding: Goldman starts SMCI at Sell with $26 target

New York, Jan 13, 2026, 14:44 EST

  • SMCI dropped roughly 6% following Goldman Sachs initiating coverage with a Sell rating and setting a $26 target
  • Goldman highlighted limited clarity on profit outlook, despite robust demand for AI servers
  • The stock has dropped steeply in the last three months, intensifying negative sentiment

Shares of Super Micro Computer (SMCI) dropped 6.3% to $28.22 Tuesday afternoon following Goldman Sachs analyst Katherine Murphy’s initiation of coverage with a Sell rating. She set a $26 price target, pointing to “limited visibility into improving profitability.” Benzinga

The warning comes as investors, once eager for artificial intelligence (AI) hardware, start focusing more on profit margins than just top-line growth. Super Micro’s shares have plunged almost 45% in the last three months, according to a Yahoo Finance report.

Goldman isn’t challenging Super Micro’s role in AI servers. Barron’s noted the bank called it a key supplier to fast-growing “neoclouds”—new cloud providers building AI data centers—like IREN and CoreWeave. Still, Goldman expects profits to take a hit, slashing its price target from $34 to $26. Margins are forecast to drop to about 7.5% in 2026, down from over 15% in 2022, Barron’s reported. Barron’s

Murphy also cautioned that large contracts can lift revenue but squeeze margins — bringing in more sales yet shrinking the portion of revenue that ends up as profit. She highlighted increased competition from both original equipment manufacturers (OEMs), who sell branded systems, and original design manufacturers (ODMs), who produce hardware for other companies.

The stakes are high since Super Micro builds servers and full racks by combining costly parts like GPUs, memory, and networking gear. Dell Technologies and Hewlett Packard Enterprise are also vying for AI data center dollars, even as chip makers maintain a firm hold on the bill of materials.

On Jan. 10, Lucas Ma of Envision Research wrote on Seeking Alpha that the market is shifting toward a more commodity-like state. He noted Super Micro is ramping up its liquid-cooled AI rack production, aiming for 5,000 racks monthly by fiscal 2026. Ma also warned that increasing DRAM and NAND prices might squeeze margins once more.

Super Micro is pushing the narrative past just big data centers. On Jan. 11, CEO Charles Liang highlighted AI’s impact on shopping in a press release tied to the NRF retail event in New York. The company is promoting edge systems designed for in-store analytics and theft prevention.

The stock has swung sharply since last year, as investors balanced rapid AI-driven growth with concerns over operational hiccups and reporting risks. In November, Super Micro revealed that last-minute configuration changes demanded by a key customer held up shipments, shifting roughly $1.5 billion in revenue from the September quarter to the December quarter.

SMCI’s shares fluctuated from $27.80 to $30.14 on Tuesday. By mid-afternoon, roughly 41 million shares had exchanged hands.

The coming quarters might still sting: if component prices rise further and customers demand steeper discounts, Super Micro’s gross margin — the portion of revenue left after hardware expenses — might struggle to recover. Any hiccup with major AI clients would quickly hit the earnings reports.

Stock Market Today

  • Jim Cramer's Top 10 Stock Market Watchlist for April 27
    April 27, 2026, 9:43 AM EDT. Stock futures hold steady despite rising oil prices after stalled Iran peace talks. Elon Musk and Sam Altman's legal dispute over OpenAI's nonprofit status heads to trial amid potential IPOs. Qualcomm shares jump 8% on partnership with OpenAI to develop smartphone chips following a surge in chip stocks. Organon rises 17% after India's Sun Pharmaceutical offers an $11.75 billion cash acquisition. Adobe faces a downgrade over AI disruption and competition concerns. Verizon beats earnings-per-share estimates, raises postpaid guidance, pushing shares up 2%. Campbell's downgraded on weakening snack segment performance. China blocks Meta's $2 billion AI startup acquisition. Markets brace amid mixed signals on tech and healthcare sectors.

Latest article

Micron Stock’s AI Memory Boom Reopens The $1 Trillion Question

Micron Stock’s AI Memory Boom Reopens The $1 Trillion Question

27 April 2026
Micron Technology shares rose 3% premarket Monday to near $497, valuing the company at about $567 billion. The stock gained after strong fiscal Q2 results, with revenue jumping to $23.86 billion and net income at $13.79 billion. Analysts cited high demand for Micron’s high-bandwidth memory used in AI chips, with new products shipping to Nvidia.
Meta Stock Faces $125 Billion AI Test as Bulls Float $1,000-Plus Targets

Meta Stock Faces $125 Billion AI Test as Bulls Float $1,000-Plus Targets

27 April 2026
Meta shares rose to $675.03 ahead of first-quarter earnings due April 29, valuing the company at $1.74 trillion. Meta has guided for Q1 revenue of $53.5–$56.5 billion and 2026 capital expenditures of up to $135 billion. Analysts project share prices could top $1,000 in coming years, but warn of regulatory and spending risks. Meta recently announced expanded use of Amazon Web Services for AI infrastructure.
Bitcoin Supply Shock? Saylor’s Latest Buy Puts Strategy Ahead Of BlackRock

Bitcoin Supply Shock? Saylor’s Latest Buy Puts Strategy Ahead Of BlackRock

27 April 2026
Strategy Inc. bought 3,273 bitcoin for $255 million last week, raising its total holdings to 818,334 BTC and keeping it ahead of BlackRock’s iShares Bitcoin Trust. Galaxy Digital CEO Mike Novogratz warned that Strategy’s pace could strain supply. Bitcoin traded near $77,660 after nine days of U.S. spot ETF inflows. Strategy funded the purchase by selling 1.45 million shares through an at-the-market program.
Pfizer stock slips as CEO likens obesity drugs to Viagra; Metsera trials and Feb. 3 earnings in focus
Previous Story

Pfizer stock slips as CEO likens obesity drugs to Viagra; Metsera trials and Feb. 3 earnings in focus

Oklo stock slides in late trade as Meta nuclear deal meets insider selling and long timelines
Next Story

Oklo stock slides in late trade as Meta nuclear deal meets insider selling and long timelines

Go toTop